Differences in Homing Potentials of Streptococcus Pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2015 Apr 4

PMID 25838267

Citations 6

Authors

Nina V Palkola

Sari H Pakkanen

Jussi M Kantele

Laura Pakarinen

Ritvaleena Puohiniemi

Anu Kantele

Affiliations

Soon will be listed here.

Abstract

Background: Mucosal immune mechanisms in the upper and lower respiratory tracts may serve a critical role in preventing pneumonia due to Streptococcus pneumoniae. Streptococcus pneumoniae-specific plasmablasts presumably originating in the lower respiratory tract have recently been found in the circulation in patients with pneumonia. The localization of an immune response can be evaluated by exploring homing receptors on such plasmablasts, yet no data have thus far described homing receptors in pneumonia.

Methods: The expression of α4β7, L-selectin, and cutaneous lymphocyte antigen (CLA) on S. pneumoniae-specific plasmablasts was examined in patients with pneumonia (n = 16) and healthy volunteers given pneumococcal polysaccharide vaccine (PPV; n = 14) or pneumococcal conjugate vaccine (PCV; n = 11).

Results: In patients with pneumonia, the proportion of S. pneumoniae-specific plasmablasts expressing L-selectin was high, the proportion expressing α4β7 was moderate, and the proportion expressing CLA was low. The homing receptor α4β7 was expressed more frequently in the pneumonia group than in the PPV (P = .000) and PCV (P = .029) groups, L-selectin was expressed more frequently in the PPV group than in the PCV group (P = .014); and CLA was expressed more frequently in the pneumonia group than in the PPV group (P = .001).

Conclusions: The homing receptor profile in patients with pneumonia was unique yet it was closer to that in PCV recipients than in PPV recipients. These data suggest greater mucosal localization for immune response in natural infection, which is clinically interesting, especially considering the shortcomings of vaccines in protecting against noninvasive pneumonia.

Citing Articles

Differential Homing Receptor Profiles of Lymphocytes Induced by Attenuated versus Live Sporozoites.

Mura M, Atre T, Savransky T, Bergmann-Leitner E Vaccines (Basel). 2022; 10(10).

PMID: 36298634 PMC: 9611729. DOI: 10.3390/vaccines10101768.

Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.

Shad T, Yousefi B, Amirifar P, Delavari S, Rae W, Kokhaei P J Clin Immunol. 2020; 41(1):76-88.

PMID: 33052516 DOI: 10.1007/s10875-020-00881-9.

Nasal vaccination of β7 integrin-deficient mice retains elevated IgA immunity.

Maslanka T, Clapp B, Hoffman C, Robison A, Gregorczyk I, Pascual D Immunol Cell Biol. 2020; 98(8):667-681.

PMID: 32479679 PMC: 9810040. DOI: 10.1111/imcb.12364.

Site-Specific DC Surface Signatures Influence CD4 T Cell Co-stimulation and Lung-Homing.

Pejoski D, Ballester M, Auderset F, Vono M, Christensen D, Andersen P Front Immunol. 2019; 10:1650.

PMID: 31396211 PMC: 6668556. DOI: 10.3389/fimmu.2019.01650.

The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications.

Carter M, Mitchell R, Meyer Sauteur P, Kelly D, Truck J Front Immunol. 2017; 8:630.

PMID: 28620385 PMC: 5451496. DOI: 10.3389/fimmu.2017.00630.

References

Kantele A, Arvilommi H, Iikkanen K, Savilahti E, Makela H, Herzog C . Unique characteristics of the intestinal immune system as an inductive site after antigen reencounter. J Infect Dis. 2004; 191(2):312-7. DOI: 10.1086/426943. View

Simell B, Auranen K, Kayhty H, Goldblatt D, Dagan R, OBrien K . The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines. 2012; 11(7):841-55. DOI: 10.1586/erv.12.53. View

Goldblatt D, Hussain M, Andrews N, Ashton L, Virta C, Melegaro A . Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005; 192(3):387-93. DOI: 10.1086/431524. View

Brandtzaeg P, Johansen F . Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev. 2005; 206:32-63. DOI: 10.1111/j.0105-2896.2005.00283.x. View

Twigg 3rd H . Humoral immune defense (antibodies): recent advances. Proc Am Thorac Soc. 2005; 2(5):417-21. DOI: 10.1513/pats.200508-089JS. View

Abonia J, Hallgren J, Jones T, Shi T, Xu Y, Koni P . Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung. Blood. 2006; 108(5):1588-94. PMC: 1895513. DOI: 10.1182/blood-2005-12-012781. View

Kayhty H, Auranen K, Nohynek H, Dagan R, Makela H . Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev Vaccines. 2006; 5(5):651-67. DOI: 10.1586/14760584.5.5.651. View

Weinberger D, Dagan R, Givon-Lavi N, Regev-Yochay G, Malley R, Lipsitch M . Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis. 2008; 197(11):1511-8. DOI: 10.1086/587941. View

Kantele A, Palkola N, Arvilommi H, Kantele J . Distinctive homing profile of pathogen-specific activated lymphocytes in human urinary tract infection. Clin Immunol. 2008; 128(3):427-34. DOI: 10.1016/j.clim.2008.05.003. View

10.

Kantele A, Hakkinen M, Moldoveanu Z, Lu A, Savilahti E, Alvarez R . Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect Immun. 1998; 66(12):5630-5. PMC: 108711. DOI: 10.1128/IAI.66.12.5630-5635.1998. View

11.

Kantele A, Zivny J, Hakkinen M, Elson C, Mestecky J . Differential homing commitments of antigen-specific T cells after oral or parenteral immunization in humans. J Immunol. 1999; 162(9):5173-7. View

12.

Cutts F, Zaman S, Enwere G, Jaffar S, Levine O, Okoko J . Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005; 365(9465):1139-46. DOI: 10.1016/S0140-6736(05)71876-6. View

13.

Moberley S, Holden J, Tatham D, Andrews R . Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013; (1):CD000422. PMC: 7045867. DOI: 10.1002/14651858.CD000422.pub3. View

14.

Angoulvant F, Levy C, Grimprel E, Varon E, Lorrot M, Biscardi S . Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis. 2014; 58(7):918-24. DOI: 10.1093/cid/ciu006. View

15.

Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X . Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis. 2014; 58(7):909-17. DOI: 10.1093/cid/ciu002. View

16.

von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C . Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014; 371(20):1889-99. DOI: 10.1056/NEJMoa1401914. View

17.

Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E . Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001; 344(6):403-9. DOI: 10.1056/NEJM200102083440602. View

18.

Campbell J, Brightling C, Symon F, Qin S, Murphy K, Hodge M . Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol. 2001; 166(4):2842-8. DOI: 10.4049/jimmunol.166.4.2842. View

19.

McEllistrem M, Mendelsohn A, Pass M, Elliott J, Whitney C, Kolano J . Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis. 2002; 185(9):1364-8. DOI: 10.1086/339882. View

20.

Xu B, Wagner N, Pham L, Magno V, Shan Z, Butcher E . Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways. J Exp Med. 2003; 197(10):1255-67. PMC: 2193791. DOI: 10.1084/jem.20010685. View